OCULAR THERAPEUTIX, INC — Form 10-Q
Filed August 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Ocular Therapeutix amended its 2021 Stock Incentive Plan authorizing up to 39.25M new shares plus up to 10.4M recycled shares from prior plans. Separately, the company signed a 10.5-year triple-net lease for 70,712 sq ft in Bedford, MA (15 Crosby Drive) at escalating rents from $16.50–$21.50/sq ft annually ($1.17M–$1.52M/year), with $1.5M letter-of-credit security deposit, commencing February 2017, terminating July 2027.
Why this rating
Plan amendment is routine equity management; lease from 2016 is historic, not current transaction. Both are administrative and immaterial to $1.6B market cap.
See more from August 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.